Home / Mesothelioma /
Mesothelioma Statistics
This chart shows the rate of mesothelioma in the U.S., independent of the increasing population. It appears to have peaked in the mid 1990’s and is now slowly declining. This is probably due to the fact that there are fewer asbestos products sold in the U.S.
SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta). Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups – Census P25-1130).
This chart shows the rate of mesothelioma in the U.S. by age for Whites, African-Americans, and Hispanics. The lines track together, but the rates are highest for Whites.
SEER Cancer Statistics Review 1975-2014
This chart compares the incidence rates of mesothelioma in the U.S. for men and women from 1975-2014. It’s clear that the rate for women is about one-quarter the rate for men. This is probably due to the fact that men have greater exposure to asbestos. In addition, we see that the peak was in the mid 1990’s but that there is a bigger decrease for men than for women. This difference has not been explained.
SEER Cancer Statistics Review 1975-2014
This chart shows the 5-year relative survival rates from 1975 to 2010. Survival rates were flat and even decreasing up to 2000. After that year, survival has steadily increased. This is due, in part, to the introduction of HIPEC for peritoneal mesothelioma and more effective surgeries for pleural mesothelioma.
SEER Cancer Statistics Review 1975-2014
Related Posts
Cost Comparison of Immunotherapy vs. Traditional Chemotherapy in Mesothelioma - A new study does a cost comparison of immunotherapy over traditional chemotherapy. Immunotherapy and chemotherapy are common in the first-line treatment of malignant pleural mesothelioma. The news came from Therapeutic Advances in Medical Oncology. Traditional Chemotherapy In 2004, the FDA approved pemetrexed for the treatment of malignant pleural mesothelioma. Pemetrexed is often taken together with cisplatin. It is for patients whose disease is either inoperable or who are not candidates for surgery. Pemetrexed + cisplatin/carboplatin are chemotherapy drugs. Chemotherapy is a group of toxic drugs that kill cells by damaging their DNA. They target both cancerous and healthy cells. Patients with this chemo regimen also take folic acid and vitamin B12 supplements. This helps to reduce side effects from the … Continue reading Cost Comparison of Immunotherapy vs. Traditional Chemotherapy in Mesothelioma 
Prognostic Factors Forecast the Future for Women with Mesothelioma - A new study in the World Journal of Surgical Oncology examines mesothelioma prognostic factors. Prognostic factors are measurable traits that can be used to estimate the chance of recovery. They can also measure the chance of mesothelioma recurring or coming back. In other words, prognostic factors can help predict the course of the disease and the future outcome. Prognostic factors are available at the time of diagnosis. They can include patient characteristics such as age, ethnicity, sex, or smoking status. And they also include disease characteristics such as disease stage or type. For mesothelioma, they may even involve the amount of asbestos exposure. The key to prognostic factors is that they must be measurable. Clinicians need a number, or a … Continue reading Prognostic Factors Forecast the Future for Women with Mesothelioma 
A Global Guide to Asbestos Consumption and Ending Mesothelioma - The World Health Organization (WHO) is working to end asbestos-related diseases, including mesothelioma. This means the end of asbestos use and consumption. New data shows the association between deaths from mesothelioma and asbestos consumption. Ecological studies play an important part in public health policy. The new Australian publication provides updated numbers about mesothelioma populations around the world. What We Knew About Mesothelioma and Asbestos 15 Years Ago A 2007 report provided clear evidence about the connection between asbestos and mesothelioma. But since that first report, only a few countries have implemented asbestos bans. Many developing countries continue to consume asbestos. Asbestos is a naturally occurring mineral that has been found throughout the world. It was once called the “magic mineral” … Continue reading A Global Guide to Asbestos Consumption and Ending Mesothelioma 
Is Right-Sided Pleural Mesothelioma Worse than Left-Sided? - Pleural mesothelioma develops from the thin layer of tissue that covers the lungs and chest wall. Pleural mesothelioma may develop in the lining of the chest wall on just one side of the chest. Previous research has suggested that right-sided pleural mesothelioma is associated with a poorer prognosis. Yet, these were very small studies and estimates were not precise. Dr. Adjepong’s team decided to see if the side mattered. Does it matter if pleural mesothelioma is more on the left or right side? Using National SEER Database to Study Pleural Mesothelioma Malignant pleural mesothelioma is a highly aggressive and rare form of cancer. There are approximately 2,000 cases of mesothelioma diagnosed in the U.S. every year. Mesothelioma is caused by exposure to … Continue reading Is Right-Sided Pleural Mesothelioma Worse than Left-Sided? 
Reviewing Twenty Years of Malignant Mesothelioma in American Women - A new study shows twenty years of national trends associated with an increase of mesothelioma deaths in American women. Inhalation of asbestos fibers can cause malignant mesothelioma. Mesothelioma is a rapidly progressing and lethal cancer. It occurs in the mesothelium, a thin layer of tissues surrounding internal organs. It is usually found in the chest and abdomen. Patients with malignant mesothelioma have a poor prognosis. They have an average survival of one year from diagnosis. The estimated average timespan from initial asbestos exposure to death is 32 years. Occupational asbestos exposure is most often reported in men. This is because they often work in industries such as construction and manufacturing. But American women are also at risk for asbestos fiber … Continue reading Reviewing Twenty Years of Malignant Mesothelioma in American Women 
Mesothelioma Patients Underrepresented in European National Cancer Data - Cancer patient surveys are important for improving healthcare practice and policy. A new study suggests mesothelioma patients may be underrepresented in this important survey. The goal of the National Cancer Patient Experience Survey is to improve European cancer care. In order to be useful, this survey should represent all cancer patients. Cancer Patient Data Collection using a National Survey Patient feedback from healthcare services is important for informing healthcare quality. And data from patient surveys directly impact policy to improve care. In the United Kingdom, there are many surveys that collect information on patient experiences. For people with cancer, a National Cancer Patient Experience Survey has been taken annually for the last 12 years. It surveys over 65,000 people with … Continue reading Mesothelioma Patients Underrepresented in European National Cancer Data 
Gender Differences in Men versus Women with Mesothelioma - Asbestos is toxic and cancer-causing for human beings. Asbestos causes mesothelioma and other asbestos related diseases. Asbestos-related diseases affect men and women differently. A recent study looked at Brazilian patients with asbestos-related diseases. These included mesothelioma, asbestosis, and lung and ovarian cancer. Introduction Mesothelioma, asbestosis, and pleural plaques are the main asbestos-related diseases. Many consider mesothelioma as the fingerprint of asbestos usage. Between 1961 and 2017, more 7 million tons of asbestos were consumed in Brazil. Mesothelioma from occupational exposure is most common in men. They were often exposed to asbestos at the job site. The number of non-occupational exposures is higher in women. Women are often exposed to asbestos from domestic and environmental sources. It has been difficult to … Continue reading Gender Differences in Men versus Women with Mesothelioma 
Mesothelioma Clinical Trials: Are Minorities Underrepresented? - The results of a new study from Harvard and Dana Farber Cancer Institute raise the question of whether ethnic minorities are being fairly represented in mesothelioma clinical trials. The study focused on four of the most common types of cancer in the US: breast, prostate, lung, and colorectal cancer. It looked at demographic data for close to 6,000 people enrolled in precision oncology trials for these cancers. Researchers found that clinical trials tend to favor white and Asian patients over Hispanic and black patients. The study could have implications for mesothelioma clinical trials of new, tailored treatments. Precision Oncology and Mesothelioma Clinical Trials Malignant mesothelioma is a challenging cancer to treat. Mesothelioma cells are good at protecting themselves from damaging … Continue reading Mesothelioma Clinical Trials: Are Minorities Underrepresented? 
Asbestos Bans Not a Quick Fix for Rising Mesothelioma Incidence - A new study is further evidence that asbestos bans are not a quick fix for the global problem of malignant mesothelioma incidence. Researchers in China and the US just released a worldwide research study on the asbestos cancer. The study included 21 regions in 195 countries and territories and spanned 27 years. The authors say mesothelioma incidence does decrease after asbestos bans. But the decrease can take decades. In the meantime, they say many countries need to do a better job of tracking and managing mesothelioma cases. Asbestos and Mesothelioma Incidence Malignant mesothelioma is an aggressive cancer with a poor prognosis. Exposure to asbestos is its only known cause. People with mesothelioma often die of this cancer in less than … Continue reading Asbestos Bans Not a Quick Fix for Rising Mesothelioma Incidence 
One in Three Mesothelioma Deaths Go Unreported in Brazil - Brazil has a history of underreporting mesothelioma deaths and the trend is not improving. That is the word from Brazilian public health experts. Their new report appears in a recent issue of Occupational Medicine. Researchers from the Institute of Collective Health in Salvador examined electronic medical records from across the country. They compared them with the official record of asbestos related diseases (ARDs) in Brazil’s Mortality Information System. They discovered that more than 300 mesothelioma deaths were missing from the roughly 1000 deaths reported between 2008 and 2014. The researchers say such underreporting makes it harder to evaluate “remedial policies” that could help prevent asbestos-linked illnesses. Asbestos in Brazil Asbestos is the primary cause of mesothelioma deaths worldwide. Mesothelioma is a … Continue reading One in Three Mesothelioma Deaths Go Unreported in Brazil 
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
— Tom Crittenden, Maricopa, Az.